Pharmaceutical Regulation, Pricing & Trade Policy

Covers global pharmaceutical regulatory frameworks including FDA approval processes, drug pricing reforms such as the Most Favored Nation model and Inflation Reduction Act, trade policy impacts including tariffs and domestic manufacturing incentives, patent exclusivity and biosimilar competition, and the intersection of regulatory compliance with market access.